100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE/Cyanine7 Anti-Human CD49d Antibody [HP1/2] (AGEL3482)

SKU AGEL3482
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG2a, k
Clone HP1/2
Conjugation PE/Cyanine7
€138 - €475

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE/Cyanine7 Anti-Human CD49d Antibody [HP1/2]

The PE-Cyanine7 Anti-Human CD49d Antibody (HP1/2) from AssayGenie is a cutting-edge research tool designed for scientists studying cell adhesion and migration processes involving the CD49d molecule. This antibody, optimized for flow cytometry analysis, offers high specificity and sensitivity for detecting CD49d expression on human samples. By binding to CD49d, it allows precise identification and characterization of this integrin subunit in various cell types, facilitating detailed investigations in immunology, oncology, and inflammatory diseases.CD49d, a key component of integrin alpha-4 beta-1, plays a pivotal role in cell adhesion, migration, and signaling pathways.

Its involvement in immune cell trafficking and interactions with vascular endothelial cells makes it a crucial target for understanding immune responses, inflammation, and cancer metastasis. Researchers can leverage the PE-Cyanine7 Anti-Human CD49d Antibody (HP1/2) to delve deeper into the mechanisms underlying these biological processes, leading to potential therapeutic strategies aimed at modulating integrin-mediated functions for clinical benefit.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose